Cancer Immunotherapy Drug Discovery Outsourcing Market (By Drug type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies and Cancer Vaccines, Others; By Cancer type - Target Identification and Validation, Lead Screening and Characterization, Cell Based Assays; By Service type - HealtLung, Breast, Colorectal, Melanoma, Prostate, Head and Neck, Ovarian, Pancreatic) - Global Industry Size, Share, Trends and Forecast 2018-2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 180

Introduction

The global cancer immunotherapy drug discovery outsourcingmarket is project worth $1.8 Billion in 2026 and the market is projected to showcase 14.0% CAGR during the forecast period. The market is driven by increasing cancer patients and surging awareness about developments and improvement in cancer immunotherapy.

Market Dynamics

Increase in occurrence of cancer disease and increasing mortality associated with cancer are the key reasons for the growth of the cancer immunotherapy drug discovery outsourcing market. Furthermore, supportive government regulation for healthcare sector is optimistically impacting the development of the market and is anticipated to drive the development during the forecast period.

Increasing number of cancer patients across the world drive the demand for better cancer treatment and diagnostics services globally during the forecast period. Also, Pharmaceutical businesses are concentrating on immunotherapies subsequently they are a potential treatment alternative for cancer due to their capability to shrink the risk of post chemotherapy tumor reoccurrence.

Furthermore, favourable tax credit permits pharmaceutical businesses to properly plan their global projects with a reputed CRO, which will help in them in growing their business and avoiding taxation related problems. This factor also contribute in the growth of the market.

Market Insights

The global cancer immunotherapy drug discovery outsourcingmarket is anticipated to account the substantial growth in the coming years, attributed to increasing alertness and awareness about developments in cancer immunotherapy paired with growing investments by pharmaceutical businesses in outsourcing and subcontracting is anticipated to boost in the growth of thecancer immunotherapy drug discovery outsourcing market.

Market Classification

The global cancer immunotherapy drug discovery outsourcing market is segmented into four major segment named drug type, service type, cancer type, and region. On the basis of drug type the cancer immunotherapy drug discovery outsourcing market is segmented intomonoclonal antibodies, immunomodulators, oncolytic viral therapies and cancer vaccines, and others. On the basis of the service type the global cancer immunotherapy drug discovery outsourcing market is segmented into target identification and validation, lead screening and characterization and cell based assays.On the basis of cancer type, the cancer immunotherapy drug discovery outsourcing market is segmented into lung, breast, colorectal, melanoma, prostate, head and neck, ovarian and pancreatic. On the basis of region the global Cancer Immunotherapy Drug Discovery Outsourcing market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Regional Insights

In 2018, North America accounts largest revenue share and the region is anticipated to continue its dominance over the forecast period as the region has domicile of big pharmaceutical giants. Other reason for the growth of the North America cancer immunotherapy drug discovery outsourcing market are high per capita healthcare expenditure, and increasing awareness about the canner treatment and diagnostic system.

Europe is anticipated to be the second fastest-developing market for cancer immunotherapy drug discovery outsourcing. Increased incidence of cancer diseases and occurrence of a huge target population base are the crucial factors growing demand for cancer immunotherapy drug discovery outsourcingin the region.

Report Coverage

Market

Cancer Immunotherapy Drug Discovery OutsourcingMarket

Analysis Period

2016– 2026

Historic Data

2016 – 2017

Base Year

2018

Forecast Data

2019 – 2026

Market Stratification

Drug type, Service type, Cancer typeand Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis,

Competitive Analysis, Player Profiling, Value Chain Analysis

Market Participants

The major players associated with the cancer immunotherapy drug discovery outsourcing market Aquila BioMedical,Crown Bioscience, Inc.,Molecular Imaging, Inc.,Explicyte,Horizon Discovery Group PLC,STC Biologics,Promega Corporation,Personalis, Inc.,HD Biosciences Co.,DiscoverX Corporation,Genscript Biotech Corporation,BPS Bioscience, Inc.,ImmunXperts SA, andCelentyx Ltd.

Market Segmentation

Market ByDrug type

  • Monoclonal Antibodies
  • Immunomodulators
  • Oncolytic Viral Therapies and Cancer Vaccines
  • Others

Market ByCancer type

  • Target Identification and Validation
  • Lead Screening and Characterization
  • Cell Based Assays

Market ByService type

  • HealtLung
  • Breast
  • Colorectal
  • Melanoma
  • Prostate
  • Head and Neck
  • Ovarian
  • Pancreatic

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

 


Related Reports

Behavioral Health Market (By Disorder: Alcohol Use Disorders, Schizophrenia, Bipolar Disorder, Depression, Anxiety, Post-traumatic Stress Disorder, Substance Abuse Disorders, Eating Disorders, Others; By Service: Emergency Mental Health Services, Outpatient Counselling, Home-based Treatment Services, Inpatient Hospital Treatment Services, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Behavioral Health market is forecasted to grow at striking CAGR around 2.5 % over the forecast time frame and reach around US$ 240 billion by 2026. Behavioural health involves non-pharmacological therapies for circumstances like mental health, drug abuse disorder, etc. Due to mental illnesses,

Transcranial Magnetic Stimulator Market (By Type: dTMS, rTMS, Others; By Application: Depression, Epilepsy) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026Transcranial Magnetic Stimulator Market (By Type: dTMS, rTMS, Others; By Application: Depression, Epilepsy) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global transcranial magnetic stimulator market size is accounted over USD 2.1 Billion by 2026 and growing at CAGR 9.0% during the forecast period 2019-2026. Transcranial magnetic stimulators are widely used in the treatment of brain and neurological diseases. The transcranial magnetic stimulators is a non-invasive technique which applies magnetic pulses to the brain that uses magnetic field to reduce chronic pain and stimu

Sacral Nerve Stimulation Market (By Product: Implantable, External; By Application: Urinary & Fecal Incontinence, Urge Incontinence, Chronic Anal Fissure, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global sacral nerve stimulation market size is expected to reach over 2.3 USD billion by 2026 at the CAGR 12.1% during the forecast period, 2019-2026. A Sacral nerve stimulation is implanted as a device to control bladder functions by delivering controlled electrical impulses to the sacral nerves that modulate the neural pathways. It is an effective and safe treatment for patients suffering fro

Medical Imaging Workstations Market (By Modality: Computed Tomography, MRI, X-ray; By Component: Visualization Software, Display Units; By Usage Mode: Thin, Thick; By Application: Diagnostic Imaging, Clinical Review; By End User: Hospital and Clinics, Diagnostics Centers, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global market for Medical Imaging Workstations is estimated to grow at a significant rate of 8.5% during the forecasted period and is expected to reach over 2.3 billion by 2026. Medical imaging workstations are used in the hospitals while setting up the equipments. During last few years there is an significant increase in the prevalence of the various diseases and accidents which has increased

Laser Hair Removal Market (End User: Dermatology Clinics, Beauty Clinics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global laser hair removal market value is accounted over USD 3.9 Billion by 2026 and is expected to grow at CAGR 15.4% during the forecast period 2019-2026. The global laser hair removal product market is driven by increased awareness regarding personal appearance and rising health awareness among the population. Additionally, improved standard of living and rising disposable income tremendously affects the laser hair remo

Idiopathic Pulmonary Fibrosis Treatment Market (By Drug Class: Tyrosine Inhibitors, MAPK Inhibitors, Autotaxin Inhibitors; By End User: Hospitals, Long-term Care Facilities, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global Idiopathic Pulmonary Fibrosis Treatment Market is expected to reach over 4.2 USD billion by 2026 and growing at CAGR 11.6% during the forecast period 2019-2026. During last few years, there is a significant increase in the number of respiratory related diseases. Increasing prevalence of the various respiratory diseases, rising geriatric population across the globe, and increasing awareness about health have driven t

Cart Summary